Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.36 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.34 |
| ▸ | DHODH | Q02127 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6240698 | 1.00 | MEN1 (0.39) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL1476623 | 0.88 | KMT2A (0.40) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL116506 | 0.88 | KMT2A (0.40) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL2601631 | 0.88 | KMT2A (0.40) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL1476620 | 0.88 | KMT2A (0.40) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL14015606 | 0.88 | KMT2A (0.40) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL4567541 | 0.83 | CES2 (0.47) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL2083176 | 0.83 | CES2 (0.47) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL2083177 | 0.83 | CES2 (0.47) | MEN1KMT2ALMNAMAPTNPSR1 | |
| SCHEMBL6241154 | 0.79 | NPSR1 (0.36) | MEN1KMT2ALMNAMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1532114-A2 | PROCESS FOR PREPARING QUINOLONE ANTIBIOTIC INTERMEDIATES | THE PROCTER & GAMBLE COMPANY (US) | 2005-05-25 | — | — | EP | disclosed |
| US-6803469-B2 | CYCLIZING IN THE PRESENCE OF A SILYLATING AGENT | THE PROCTER & GAMBLE COMPANY | 2004-10-12 | — | — | US | disclosed |
| US-20040063952-A1 | Process for preparing quinolone antibiotic intermediates | WARNER CHILCOTT COMPANY, LLC | 2004-04-01 | — | — | US | disclosed |
| WO-2004013103-A2 | PROCESS FOR PREPARING QUINOLONE ANTIBIOTIC INTERMEDIATES | THE PROCTER & GAMBLE COMPANY (US) | 2004-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063952-A1 | Process for preparing quinolone antibiotic intermediates | QPCT, CCNT1, TOP1 | MEN1 1557/4885KMT2A 1408/4885LMNA 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.